<span id="midArticle_start"/>May 25 AB Science SA :
<span id="midArticle_0"/>* Announces issuance of a new U.S. patent for masitinib inthe treatment of severe persistent asthma
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>* Patent extends protection for use of masitinib in asthmauntil 2032Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
<span id="midArticle_2"/> <span class="third-article-divide"/>
<span id="midArticle_0"/>* Announces issuance of a new U.S. patent for masitinib inthe treatment of severe persistent asthma
<span id="midArticle_1"/> <span class="first-article-divide"/> <span class="second-article-divide"/>* Patent extends protection for use of masitinib in asthmauntil 2032Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
<span id="midArticle_2"/> <span class="third-article-divide"/>
via Smart Health Shop Forum http://ift.tt/1HGNM4y
No comments:
Post a Comment